Ing Groep Nv Boston Scientific Corp Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Boston Scientific Corp stock. As of the latest transaction made, Ing Groep Nv holds 196,950 shares of BSX stock, worth $17.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

196,950

Previous 197,831 0.45%

Holding current value

$17.9 Million

Previous $15.2 Million 8.34%

% of portfolio

0.1%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$72.96 - $84.0 $64,277 - $74,004	-881 Reduced 0.45%	196,950 $16.5 Million
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $2.24 Million - $2.58 Million	-33,215 Reduced 14.38%	197,831 $15.2 Million
Q1 2024 May 10, 2024	BUY	$57.6 - $68.62 $9.62 Million - $11.5 Million	167,091 Added 261.26%	231,046 $15.8 Million
Q4 2023 Feb 08, 2024	SELL	$48.64 - $57.81 $5.83 Million - $6.93 Million	-119,865 Reduced 65.21%	63,955 $3.7 Million
Q3 2023 Oct 27, 2023	SELL	$50.19 - $54.68 $5.21 Million - $5.68 Million	-103,901 Reduced 36.11%	183,820 $9.71 Million
Q2 2023 Aug 07, 2023	BUY	$49.72 - $54.64 $8.11 Million - $8.91 Million	163,029 Added 130.75%	287,721 $15.6 Million
Q1 2023 May 09, 2023	SELL	$45.09 - $50.03 $5.21 Million - $5.78 Million	-115,623 Reduced 48.11%	124,692 $6.24 Million
Q4 2022 Feb 10, 2023	BUY	$39.56 - $47.22 $630,467 - $752,545	15,937 Added 7.1%	240,315 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1.71 Million - $5.11 Million	-46,577 Reduced 17.19%	224,378 $8.69 Million
Q2 2022 Aug 08, 2022	BUY	$35.24 - $47.1 $1.58 Million - $2.11 Million	44,873 Added 19.85%	270,955 $10.1 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $1.6 Million - $1.76 Million	39,124 Added 20.93%	226,082 $10 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $2.5 Million - $2.95 Million	65,739 Added 54.23%	186,958 $7.94 Million
Q3 2021 Nov 02, 2021	BUY	$41.23 - $45.88 $105,466 - $117,361	2,558 Added 2.16%	121,219 $5.26 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $882,324 - $1.01 Million	22,870 Added 23.87%	118,661 $5.07 Million
Q1 2021 May 12, 2021	BUY	$35.27 - $39.67 $28,674 - $32,251	813 Added 0.86%	95,791 $3.7 Million
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $2.1 Million - $2.66 Million	63,315 Added 199.97%	94,978 $3.41 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $674,300 - $826,821	19,579 Added 162.02%	31,663 $1.21 Million
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $404,968 - $524,621	-13,414 Reduced 52.61%	12,084 $424,000
Q1 2020 May 06, 2020	SELL	$25.83 - $45.71 $232,650 - $411,709	-9,007 Reduced 26.1%	25,498 $832,000
Q4 2019 Feb 10, 2020	SELL	$37.87 - $45.37 $1.99 Million - $2.38 Million	-52,430 Reduced 60.31%	34,505 $1.56 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $3.5 Million - $3.78 Million	86,935 New	86,935 $3.54 Million
Q2 2019 Aug 12, 2019	SELL	$34.91 - $42.98 $7.21 Million - $8.87 Million	-206,425 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $6.6 Million - $8.18 Million	200,648 Added 3473.22%	206,425 $7.92 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $5.88 Million - $7.23 Million	-185,298 Reduced 96.98%	5,777 $204,000
Q3 2018 Nov 06, 2018	BUY	$32.83 - $38.63 $6.27 Million - $7.38 Million	191,075 New	191,075 $7.36 Million
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $3.77 Million - $4.82 Million	-140,480 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$25.2 - $28.54 $2.77 Million - $3.14 Million	109,914 Added 359.6%	140,480 $3.84 Million
Q4 2017 Feb 06, 2018	SELL	$24.79 - $29.8 $442,451 - $531,870	-17,848 Reduced 36.87%	30,566 $758,000
Q3 2017 Nov 08, 2017	BUY	$26.26 - $29.17 $1.27 Million - $1.41 Million	48,414	48,414 $1.41 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account